Postoperative Pain and Length of Stay Lowered by Use of Exparel in Immediate, Implant-Based Breast Reconstruction

BACKGROUND: Patients undergoing mastectomy and prosthetic breast reconstruction have significant acute postsurgical pain, routinely mandating inpatient hospitalization. Liposomal bupivacaine (LB) (Exparel; Pacira Pharmaceuticals, Inc., Parsippany, N.J.) has been shown to be a safe and effective pain...

Descripción completa

Detalles Bibliográficos
Autores principales: Butz, Daniel R., Shenaq, Deana S., Rundell, Veronica L. M., Kepler, Brittany, Liederbach, Eric, Thiel, Jeff, Pesce, Catherine, Murphy, Glenn S., Sisco, Mark, Howard, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457254/
https://www.ncbi.nlm.nih.gov/pubmed/26090281
http://dx.doi.org/10.1097/GOX.0000000000000355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457254/
https://www.ncbi.nlm.nih.gov/pubmed/26090281
http://dx.doi.org/10.1097/GOX.0000000000000355

Ejemplares similares